US Patent Issued to Beren Therapeutics P.B.C. on Nov. 3 for "Isomerically pure beta-cyclodextrin derivatives and uses thereof" (California Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,779,038, issued on Nov. 3, was assigned to Beren Therapeutics P.B.C. (Thousand Oaks, Calif.).

"Isomerically pure beta-cyclodextrin derivatives and uses thereof" was invented by Dustin McMinn (Thousand Oaks, Calif.) and Brad Herberich (Thousand Oaks, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are novel compounds of Formula I, Ia, Ib, Ic, Id, Ie, or If, useful in treating diseases in which cholesterol is implicated, including cardiovascular diseases."

The patent was filed on Feb. 13, 2026, under Application No. 19/539,178.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netac...